Should the COVID-19 Vaccine’s Intellectual Property Be Accessible for Everyone?

 

Key Words:

  • Intellectual property protection is important because you have rogue scientists and organizations who might try and do a knock off of the vaccine that isn’t the same quality, which could be dangerous because it isn’t as effective.
  • Pharmaceutical companies shouldn’t be making profit off of drugs that treat neglected diseases.
  • Accessibility of the COVID-19 vaccine such as the inability to properly store the vaccine, is one of the biggest problems for certain parts of the world when it comes to vaccine distribution.

Commentary:

Although the COVID-19 vaccine is readily available, it isn’t necessarily available for everyone. Some countries across the globe do not have access to the vaccine partially because of intellectual property claims. Intellectual properties protect the patents of drugs like the COVID-19 vaccine, making it so that the information on how to make it, is only shared with a select group of people. Right now there is a battle over whether or not countries like the United States should share the IP of the COVID-19 vaccine. MarketScale reached out to Dr. Kishor Wasan about this topic and we asked his opinion on the World Trade Organization and TRIPS Council’s decision to lean so heavily on protecting IPs rather than what some may argue is looking out for the global good by making the COVID-19 vaccine more accessible.

Abridged Thoughts:

So intellectual property is partly there because yes, it’s there so they can make money and protect their invention. But at the same time, it’s also there so that, the product is protected, so that people don’t do rogue products and make a substandard version of it. That’s why this is actually a very controversial and tricky issue. It’s not that black and white. I mean, it’s not as simple as that. So you have to kind of keep those two things in mind. And again, it comes down to a balance between the two.

More Stories Like This:

Medical Professionals Leave and Join the Industry in Droves. How Should This Shape Healthcare Education?

Is It Time to Revamp the Drug Development Pipeline?

Follow us on social media for the latest updates in B2B!

Image

Latest

Vogel
Empowering Through Connection: Vogel’s Pyramid Model Approach
July 19, 2024

Mission and Impact: Vogel Alcove, a nonprofit in Dallas, helps homeless children and families through various programs and services. Pyramid Model Framework: Vogel uses the Pyramid Model, an evidence-based framework for promoting young children’s social-emotional development with universal supports, targeted supports, and intensive interventions. Nurturing Relationships and Supportive Environments: Vogel focuses on building nurturing…

Read More
MedPAC
MedPAC’s Miss on Reality of Home Health Financial Reality Results in Suggested Cut in 2025 Proposed Rule
July 19, 2024

The March 2024 MedPAC report recommending a 7% payment reduction for home health agencies in 2025 has sparked significant concern within the industry. Why is this recommendation being met with such resistance, and what does the financial reality of home health agencies look like in contrast to these federal suggestions? Are the MedPAC recommendations…

Read More
baseball game
Sixth Inning- What are the Stages Where Your Business Takes Place?
July 18, 2024

When you think of a baseball game, you might picture the crack of the bat or the roar of the crowd as a home run sails over the outfield fence. But for the Savannah Bananas, the game is just one part of the spectacle. Jesse Cole, the mastermind behind this innovative team, shares how…

Read More
skilled trades career
A Skilled Trades Career Provides a Future-Proof Path
July 18, 2024

In today’s rapidly changing job market, a skilled trades career offers a viable and attractive option, especially for the younger generations exploring alternatives to traditional college education. Recent trends indicate a significant shift in interest in these hands-on professions. On Straight Outta Crumpton, host Greg Crumpton engages in a lively conversation with Nicole Bass,…

Read More